Psychedelic Stocks Archives - Page 23 of 61

WednesdayAug 09, 2023 1:52 pm

Animal Study Shows Psilocybin Fix Cognitive Deficits Resulting from Stress-Related Depression

A recent study published in the “Psychedelic Medicine” journal has reported that psilocybin possesses effects akin to antidepressants and may alleviate cognitive deficits resulting from chronic stress in animal models. Psilocybin is a hallucinogenic compound produced in magic mushrooms. Although it has been used recreationally for decades because of its hallucinatory effects, a growing body of research now shows that psilocybin may also have a myriad of mental health benefits. This research has found that psilocybin as well as other psychedelic compounds such as LSD and ayahuasca can treat various mental-health conditions, offering relatively long-term relief at low doses and…

TuesdayAug 08, 2023 12:10 pm

Study Compares Human Brains During Meditation, Hypnosis, Under Psychedelics

Researchers from the University of Zurich Psychiatric Hospital are comparing what happens to the human brain during meditation and hypnosis, as well as while under the effects of psychedelics. Brain changes while under the influence of drugs or during states such as hypnosis and meditation have been an object of interest for researchers for quite a while now. Now that psychedelics have emerged as potential mental health treatments with much higher success rates and fewer side effects, researchers are even more interested in how drugs like psychedelics cause changes in the brain. University of Zurich researchers were particularly interested in…

MondayAug 07, 2023 3:29 pm

California Ballot Measure Seeks to Create Psychedelics Research Agency

A California-based physician has filed a ballot measure that would invest $5 billion into researching the potential benefits of using psychedelics to treat specific mental disorders. The proposed bond initiative would use billions of dollars in state funds to support the study of psychedelics such as psilocybin, ketamine and LSD as potential mental health treatments. Last month, Los Angeles-based internal medicine physician Dr. Jeannie Fontana filed paperwork to place the Treat California Initiative on the November ballot. The measure would also call for the creation of a new agency to study the impact of psychedelic-assisted therapy on people with mental…

FridayAug 04, 2023 12:01 pm

Study Sheds Light on How Psychedelics Affect Social Cognition, the DMN, and ToM

Research into psychedelics has revealed that the Default Mode Network (DMN), a series of interconnected regions in the brain that are involved in introspection, may play a role in how psychedelics deliver their effects. The DMN is associated with self-criticism and self-reflection and exhibits amplified activity when people take part in tasks that require interacting with and understanding others. Conversely, prior research has found that an overactive Default Mode Network may also be associated with obsessive-compulsive disorder (OCD), anxiety and depression. On the other hand, the Theory of Mind (ToM) Network has been tied to perspective taking, the ability to…

ThursdayAug 03, 2023 2:10 pm

Study Evaluates Whether Neuropathic Pain, Depression Can Be Simultaneously Treated by Psilocybin

Chronic pain is one of the most prolific causes of disability on the planet, forcing millions of people worldwide to deal with debilitating pain on a daily basis and costing the global economy billions of dollars. Although the condition occurs due to a variety of reasons, the similarity among all people with chronic and neuropathic pain is that it causes significant physical and mental suffering, as well as stress and insomnia that exacerbate the risk of developing depression. The physical limitations neuropathic pain places on patients can also prevent people from taking part in day-to-day activities and favorite hobbies, reducing…

WednesdayAug 02, 2023 1:45 pm

Study Explores Similarities Between Psychedelics, Near-Death Experiences

Psychedelics are all the rage these days thanks to a major surge in psychedelic research and media reporting on hallucinogens. This research has revealed that various psychedelics may have significant mental health benefits, making the substances prime candidates as alternatives for often unreliable modern psychiatric medications. Researchers are especially interested in how psychedelics affect the brain and mind as they seem capable of delivering profound and long-term benefits against hard-to-treat mental conditions such as post-traumatic stress disorder, eating disorders and treatment-resistant depression. In a recent study on psychedelics, researchers sought to understand the similarities between near-death experiences during a coma…

TuesdayAug 01, 2023 11:00 am

MDMA Therapy Could Help PTSD Patients Tame Chronic Pain

A new open-label study published in the “Frontiers in Psychiatry” journal has discovered that MDMA may be effective at treating chronic pain in patients with post-traumatic stress disorder (PTSD). The 33 participants involved in the study had been diagnosed with severe PTSD and were instructed to cease using additional psychiatric treatments during the study. PTSD-afflicted individuals who took part in the study reported reductions in pain levels after undergoing MDMA-assisted therapy; individuals with the highest chronic pain levels reporting the most significant relief. According to the study, 84% of the study group had chronic pain and 75% claimed that the…

MondayJul 31, 2023 12:07 pm

Early Trials Suggest Psychedelics Could Treat Anorexia

American researchers studying the effects of psychedelics on eating disorders have found that psilocybin, the main hallucinogenic agent in magic mushrooms, may be able to treat anorexia. U.S. researchers ran the small study, which involved 10 adult women aged 18 to 40 years of age. Eating disorders such as anorexia, binge eating and bulimia nervosa are some of the most dangerous mental disorders in the United States, taking one life every 52 minutes and costing the country $64.7 billion yearly in medical costs. They are second only to opioids in terms of deadliness and are extremely hard to treat due to…

FridayJul 28, 2023 11:33 am

Study Suggests SNRIs, SSRIs Reduce Effects of Psilocybin

Findings from a recent study have revealed that SSRI and SNRI use may weaken the effects of psilocybin (magic mushrooms). The researchers were specifically interested in the extent to which antidepressants could diminish the effects of psilocybin when they were taken alongside the psychedelic and after antidepressant use is halted. Psychedelics are predicted to revolutionize the psychiatric industry in a major way due to their purported mental health benefits. A series of studies have found that psychedelic drugs such as psilocybin, MDMA and LSD may be able to treat mental conditions anxiety, depression, post-traumatic stress disorder, and even eating disorders.…

ThursdayJul 27, 2023 1:44 pm

Kentucky Commission Receives Expert Testimonies on Psychedelics Benefits as Opioid Treatments

The Kentucky Opioid Abatement Advisory Commission has begun taking expert testimonies on the benefits of using psychedelics to treat opioid use disorder. Psychedelics have emerged as a potential alternative treatment to a wide variety of mental disorders in recent years, thanks to an influx of psychedelic-based research. Scientists have found that psychedelic compounds such as psilocybin can aid in the treatment of conditions, including post-traumatic stress disorder, anxiety, depression and substance-use disorder. A panel of experts in Kentucky is now receiving testimonies on the potential benefits of incorporating psychedelic-assisted therapy into opioid use disorder treatment protocols. The panel comprised of…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000

Category: Psychedelic Stocks